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ABSTRACT 
Upon entering physiological environments, nanoparticles readily assume the form of a 
nanoparticle-protein corona that dictates their biological identity. Understanding the structure 
and dynamics of nanoparticle-protein corona is essential for predicting the fate, transport, and 
toxicity of nanomaterials in living systems and for enabling the vast applications of 
nanomedicine. We combined multiscale molecular dynamics simulations and complementary 
experiments to characterize the silver nanoparticle-ubiquitin corona formation. Specifically, 
ubiquitins competed with citrates for the nanoparticle surface and bound to the particle in a 
specific manner. Under a high protein/nanoparticle stoichiometry, ubiquitions formed a multi-
layer corona on the particle surface. The binding exhibited an unusual stretched-exponential 
behavior, suggesting a rich kinetics originated from protein-protein, protein-citrate, and protein-
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nanoparticle interactions. Furthermore, the binding destabilized the α-helices while increasing 
the β-sheets of the proteins. Our results revealed the structural and dynamic complexities of 
nanoparticle-protein corona formation and shed light on the origin of nanotoxicity. 
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Nanomaterials have been increasingly applied in consumer products due to their unique 
physical and chemical properties. The increasing application of nanomaterials in daily life 
inevitably leads to their accumulation in the environment1 and subsequent entry into biological 
systems, causing bio-safety concerns related to nanotechnology2. Nanoparticles have also been 
found useful in disease diagnostics, drug and gene delivery, and therapeutics3-5. Therefore, the 
safety issue of nanotechnology is pressing, and the study of nanotoxicology has attracted much 
research interest recently6. The benefits of understanding the interactions between nanoparticles 
and biological systems extend from fundamental physical sciences to nanomedicine, 
nanotoxicology, nanoecotoxicology, consumer usages, and the public’s perception of 
nanotechnology.  
 
Upon entering biological systems such as the bloodstream, a nanoparticle forms molecular 
complexes with encountered proteins, termed as the protein corona7. Protein corona shields the 
surface of the exogenous nanoparticle and subsequently determines the biological properties of 
the nanoparticle core. On the other hand, interactions with nanoparticles can also alter the 
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structure, dynamics, and function of the bound proteins, which could further impact recognition 
of the proteins by membrane receptors and the immune system. Previous experimental studies 
have provided much insight, such as the existence and size of the protein corona8, and protein 
composition on the nanoparticle surface9. However, due to limitations in instrument resolution, 
the molecular detail of protein-nanoparticle interaction remains poorly understood. 
Computational modeling, in contrast, provides a useful approach to bridge the gap between 
experimental observation and the molecular systems of interest. Here we performed both 
computational and experimental characterisations of protein corona formation between a silver 
nanoparticle (AgNP) and ubiquitin protein. Silver nanoparticles are widely used in commercial 
products for their antibacterial and antifungal properties10, while ubiquitin is ubiquitously 
expressed in all eukaryotic cells regulating protein distribution and recycling, thereby making 
AgNP and ubiquitin a representative model system for studying nanoparticle-protein interaction 
and corona formation.  
 
Two major challenges arise in computational modeling of protein corona.  First is the large 
system size — where an abundance of proteins interacts with nanometer-sized nanoparticles, 
second is the long timescales associated with protein corona formation. Traditional molecular 
dynamics approaches can accurately describe the molecular system of nanoparticles and 
proteins11, 12, but are not able to reach the relevant time and length scales needed for depicting 
their interactions till equilibration. To overcome this barrier, we adopted a multiscale modeling 
approach13, which coherently blended atomistic and coarse-grained simulations14, 15. All-atom 
simulations were first performed to investigate the possible binding modes between an individual 
ubiquitin and a AgNP, and the knowledge of AgNP-ubiquitin binding was then incorporated into 
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the construction of a coarse-grained model. With the coarse-grained simulations, we were able to 
extensively characterise the structure and dynamics of AgNP interacting with multiple ubiquitin 
molecules (up to 50). The dynamics of both atomistic and coarse-grained models were sampled 
by discrete molecular dynamics (DMD)16, an efficient sampling method for underpinning protein 
dynamics (Supporting Materials). 
 
We first performed atomistic simulations of a molecular system comprised of one ubiquitin 
molecule and one citrate-coated AgNP (Supporting Materials). The simulations were performed 
with implicit solvent, and the inter-atomic interactions were modeled by a physical force field 
adapted from Medusa17, which include van der Waals, solvation18, electrostatic, and hydrogen 
bond potentials. The coarse-grained silver atoms of the AgNP were assigned as hydrophobic 
with a small fraction being positively charged to account for the nanoparticle surface charges19. 
During simulations, we kept the center of the AgNP static, while allowing the ubiquitin and the 
citrates to move freely in the simulation box and surface silver atoms mobile on the NP surface. 
 
To evaluate whether ubiquitin could bind to AgNP, we performed DMD simulations near 
room temperature with a ubiquitin molecule initially positioned away from a citrate-coated 
AgNP (Fig. 1a).  Interestingly, we found that the neutrally-charged ubiquitin did not bind to the 
hydrophobic surface of AgNP, but instead attracted to the surface charge of the AgNP by 
replacing the surface-bound citrates (-3e at neutral pH) that were stabilized by electrostatic 
interactions (Fig. 1a). Although ubiquitin does not have a net charge, it does possess eleven 
positively-charged and eleven negatively-charged residues out of the 76 total residues20. Near the 
surface of the ubiquitin helix, negatively-charged residues formed a cluster with low electrostatic 
 5 
potentials (Fig. 1b), which allowed stronger binding to the AgNP in simulations than did the 
negatively-charged citrates. The binding of ubiquitin to AgNP was consistent with our UV-vis 
absorbance measurement (Fig. 1c), where a redshift from 393 nm (peak wavelength for AgNP 
absorbance) to 407 nm (peak wavelength for AgNP-ubiquitin absorbance) indicated an increased 
dielectric constant likely resulting from nanoparticle-protein complex formation. Consistently, 
our dynamic light scattering measurement showed a hydrodynamic size of 34.5 nm for AgNP-
ubiquitin (zeta potential: 12.3 mV), compared to that of 4.8 nm for ubiquitins (zeta potential: 4.6 
mV) and 13.6 nm for AgNP (zeta potential: -45.0 mV), further corroborating their effective 
binding.  
 
To test whether electrostatic interaction was the driving force for AgNP-ubiquitin binding, we 
artificially enhanced the binding affinity between citrates and AgNP by adding an additional 
charge to the citrate molecule (Supporting Materials). For both the case of artificially-enhanced 
electrostatic interactions and the regular (non-enhanced) case, we performed ten independent 
atomistic DMD simulations with different initial AgNP/ubiquitin configurations. For a higher 
citrate-AgNP affinity due to enhanced electrostatic interactions, we did not observe any AgNP-
ubiquitin binding in all simulations. In the case of regular citrate-AgNP interactions, we 
observed AgNP-ubiquitin binding for seven out of the ten simulations. The computed 
distributions of citrates from the AgNP also illustrated that the ability for ubiquitin to displace 
citrates and bind AgNP depended upon the electrostatic-dominating affinity between the citrates 
and the AgNP (Fig. 1d). Therefore, the binding of ubiquitin to AgNP was mainly determined by 
electrostatic interactions. 
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Based on the ensemble of ubiquitin-bound complex structures derived from seven independent 
DMD simulations, we computed for each residue the probability of forming contact with the 
nanoparticle (Supporting Materials). Only a subset of residues had significantly high AgNP 
contact frequency, PAgNP, while the rest of the protein did not interact with the AgNP (Fig. 2a). 
The histogram of PAgNP featured a bimodal distribution, with one peak close to zero and the other 
centered around PAgNP ~ 0.4  (Fig. 2b). We further determined the AgNP-binding residues (Fig. 
2b insert) as those with PAgNP larger than 0.3, the median value separating two peaks in the 
histogram. These residues were located near the protein helix, coinciding with the cluster of 
negatively-charged residues (Fig. 1b). Importantly, one of the AgNP-binding residues, Asp18 
(PAgNP = 0.52), had been experimentally determined to bind gold nanoparticle (AuNP) by nuclear 
magnetic resonance (NMR) studies21. Since AgNP and AuNP are comparable both physically 
and chemically, we believe that the modes of their binding with ubiquitin are also comparable. 
This agreement between NMR observations and simulations highlights the predictive power of 
our computational methods.  
 
In order to observe the formation of AgNP-ubiquitin corona in silico, it is necessary to include 
multiple proteins in simulations, which is beyond the capacity of atomistic simulations. Instead, 
we used a two-bead-per-residue model22 to represent ubiquitin and a single atom to model each 
citrate. The inter- and intra-ubiquitin interactions were modeled by a structure-based potential 
model23, 24, which has been extensively used in computational studies of protein folding and 
protein aggregation15. The specific interactions between the AgNP surface charges and ubiquitin 
residues as well as other non-specific inter-molecule interactions were modeled according to 
atomistic DMD simulations (Supporting Materials).  
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We investigated AgNP-ubiquitin corona formation by performing DMD simulations of the 
coarse-grained system, with multiple ubiquitins (25 molecules) initially positioned randomly 
with respect to a citrate-coated AgNP. The temperature of the simulation system was kept below 
the melting temperature of ubiquitin in order to mimic the physiological conditions, where the 
protein remains folded (Supporting Materials). To avoid potential biases associated with initial 
conditions, we performed ten independent simulations assuming different initial configurations 
and velocities. For each simulation we monitored the number of ubiquitins bound to the AgNP, 
Nbound, as a function of time. All trajectories in Fig. 3a featured an initial fast binding, which 
slowed down as time progressed. Interestingly, the average Nbound did not follow a typical single-
exponential binding kinetics, ~ 1-exp(-λt), which usually features a power-law with the exponent 
of 1 during initial binding in a log-log plot (Fig. 3b). Instead, the exponent is ~0.23 < 1, 
corresponding to a stretched-exponential binding kinetics, ~ 1-exp(-ctα). This unusual behavior 
might be related to multiple factors that governed AgNP-ubiquitin binding kinetics, including 
non-specific interactions with other proteins, decreased ubiquitin concentration, depletion of 
available binding sites for incoming ubiquitins, and competition with citrates. The binding 
affinity between citrate and AgNP was concentration-dependent, and increased as ubiquitins 
displaced AgNP-bound citrates to subsequently increase the citrate concentration in solution. All 
these factors could hinder the binding of ubiquitins to the AgNP surface, leading to the stretched 
exponential binding kinetics. Therefore, our coarse-grained simulations revealed a rich kinetics 
for nanoparticle-protein binding, which may need to be considered in future kinetic and 
mesoscopic modeling of corona formation, such as studies of the Vroman effect of abundant 
proteins for a nanoparticle entering the bloodstream25. 
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The AgNP-ubiquitin complex structure derived from simulations had multiple ubiquitins 
bound to the surface of one AgNP, forming a single-layer protein corona (Fig. 3c). The majority 
of AgNP-bound proteins stayed folded under the particular simulation condition (Supporting 
Materials) and bound to the surface of the AgNP with the protein helix facing the nanoparticle. 
Only in one of the simulations, one ubiquitin out of the 22 AgNP-bound proteins partially 
unfolded and the conformation was stabilized by extensive contacts with the hydrophobic surface 
of the AgNP (Fig. 3c). In addition, we explored the effect of protein concentration on corona 
formation by performing DMD simulation for a higher ubiquitin/AgNP stoichiometry of 50:1. In 
these simulations, ubiquitins competed with citrates for binding to the AgNP (Fig. 3d). The final 
structure featured multiple layers of protein corona, whereas the first layer was dominated by 
specific binding between ubiquitins and the AgNP, and the outer layers were stabilized by 
protein-protein interactions (Fig. 3e). The AgNP-ubiquitin complex structures derived from the 
coarse-grained simulations successfully revealed an atomic picture of the nanoparticle-protein 
corona. 
 
The ability of nanoparticles to induce protein unfolding (Fig. 3c) could be one of the 
mechanisms of nanotoxicity. To evaluate the impact of AgNP-binding on ubiquitin 
conformation, we computed for each protein residue the fraction of native contacts (Q-value26) 
for both the AgNP-bound and unbound ubiquitins (Fig. 4a). A residue with its Q-value close to 1 
maintains a native-like structure, while losing its structure if the Q-value is near 0. Both the 
AgNP-bound and unbound ubiquitins maintained native-like structures with most regions having 
their Q-values close to 1. Only loop regions between the secondary structures (18-19, 32-35, and 
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46-53) had relatively low Q-values. The difference in the Q-values for AgNP-bound and 
unbound ubiquitins suggests that residues in contact with the AgNP were stabilized upon binding 
(the regions with positive differences coincided with the residues bound to AgNP, Fig. 2a). Two 
regions, one near the C-terminal of the helix and the other close to residue 46 in a loop, were 
significantly destabilized upon binding. The destabilization of protein helix due to AgNP-binding 
is consistent with our circular dichroism (CD) measurement (Supporting Materials), which 
revealed that the helical content was reduced by 5% for the AgNP-bound ubiquitins compared to 
the free ubiquitins (Fig. 4b). The increase of β-sheet content could be due to the formation of 
inter-protein hydrogen bonds between partially unfolded protein regions, since the protein 
concentration was locally enriched on the AgNP surface.  
 
In summary, both our computer simulations and experiments showed that ubiquitins could 
readily bind to citrate-coated AgNP. Our multiscale modeling revealed a specific binding 
between ubiquitins and AgNP, where electrostatic interaction was attributed as the primary 
driving force. This predicted binding mode is consistent with previous NMR experiments on 
AuNP-ubiquitin binding. Most notably, our coarse-grained simulations of AgNP-ubiquitin 
corona formation uncovered an unusual stretched exponential binding kinetics, suggesting 
complex interactions occurring between AgNP and proteins that may have great relevance to 
future studies of nanoparticles interacting with biomolecular amphiphiles. At a high 
stoichiometry, specifically, ubiquitins formed a multi-layer corona surrounding the AgNP. Both 
our simulations and experiments showed that AgNP-binding destabilized the α-helix while 
increased the β-sheet content of the ubiquitins. The binding with AgNP altered protein 
conformation, which may impair recognition of ubiquitin by its binding partners and trigger 
immune response, act as one of the causes of AgNP-induced cytotoxicity, in addition to ion 
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dissolution that has been accepted as a paradigm for AgNP toxicity10. Taken together, our new 
multiscale modeling has shown a remarkable predictive power for describing the structural and 
dynamic characteristics of nanoparticle-protein corona, a topic that is poorly understood and yet 
underlies our interpretation of the transformation and biocompatibility of nanoparticles, and has 
broad implications in the basic and applied areas of molecular self assembly, nanomedicine, 
sensing, bioimaging, nanobiophysics, and the health and safety of nanotechnology. 
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FIGURES 
Figure 1. Interaction between a single ubiquitin and a citrate-coated AgNP. (a) Initial (t = 0 
ns) and final (t = 50 ns) structure of the ubiquitin-citrate-AgNP complex system. The ubiquitin is 
represented as cartoons, the side chains as lines, and the citrates as sticks. The gray sphere 
represents the nanoparticle, and the charged atoms on the AgNP surface are shown as blue 
spheres. Zoom-in view of the final structure indicates the binding between the ubiquitin and a 
charged AgNP surface atom. (b) The positively (aspartate and glutamate) and negatively (lysine 
and arginine) charged residues in ubiquitin are shown as sticks (left panel). The surface 
electrostatic potential (computed using PyMol, www.pymol.org) illustrates the cluster of 
negatively charged atoms near the protein helix (right panel). (c) The UV-vis absorbance of 
AgNP, ubiquitin, and AgNP-ubiquitin, featuring a redshift of the absorbance peaks for AgNP-
ubiquitin and AgNP alone due to dampened surface plasmon resonance. (d) Distributions of 
citrates around AgNP (solid lines) derived from the simulations. The electrostatic (ES) 
interaction between citrate and AgNP was artificially enhanced in one case. The dashed lines 
correspond to the accumulative probability. The horizontal dashed line corresponds to charge 
saturation, where the total charge of citrates equal that of the AgNP. 
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Figure 2. Specific binding between ubiquitin and AgNP. (a) The contact probability between 
AgNP and each ubiquitin residue, computed from independent all-atom DMD simulations 
(Supporting Materials). (b) The histogram of the AgNP-ubiquitin contact probability displays a 
bimodal distribution. The ubiquitin residues with high contact frequency (> 0.3; corresponding to 
the second peak) to the AgNP are shown in sticks (insert). The residue Asp18 was also found to 
interact with gold nanoparticle21. 
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Figure 3. Ubiquitin-AgNP corona formation. (a) The number of ubiquitin molecules bound to 
AgNP, Nbound, was computed as the function of time (in DMD time unit, t.u., see Supporting 
Materials) from ten independent simulations (in different colors) of the coarse-grained molecular 
system. (b) The average number of ubiquitins bound to AgNP, <Nbound>, features a power-law 
(approximately linear) in a log-log plot. The exponent is approximately ~0.23. (c) The final 
structure from one of the simulations (corresponding to the black line with the highest Nbound in 
panel a). The ubiquitins are in cartoon representation. The citrates correspond to the red spheres. 
The large dark-green sphere denotes the AgNP, and the blue spheres on the surface of the AgNP 
are the positively charged atoms. One of AgNP-bound ubiquitin is unfolded on the nanoparticle 
surface (right). In a coarse-grained DMD simulation with a higher stoichiometry of ubiquitin to 
AgNP (50:1), ubiquitin (black line) competed with citrate (red) to bind AgNP by displacing 
initially-bound citrates (d). At this high stoichiometry, multi layers of ubiquitins were found to 
deposit onto the surface of the AgNP (e).  
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Figure 4. The structural change of ubiquitin upon AgNP binding. (a) The fraction of native 
contacts, Q-value, was computed for each residue for both the AgNP-bound (black) and unbound 
(blue) ubiquitins (top panel). The error bars were estimated from independent simulations. The 
yellow arrows indicate the residue segments forming β-strands, and the red rod denotes the 
residues forming the α-helix. The differences of Q-value were computed between AgNP-bound 
and unbound (bottom panel) cases. The two dashed lines correspond to deviations with one 
standard deviation above and below the average. The differences beyond the two lines are 
statistically significant. (b) The percentage of secondary structures in ubiquitin (dark blue) and in 
AgNP-ubiquitin (cyan) were probed by CD experiments (Supporting Materials). 
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